Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 12, 2022 | Series A | $30M | 2 | Versant Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | Yes | Series A |
Black Diamond Therapeutics | — | Series A |